0001104659-21-145591.txt : 20211201
0001104659-21-145591.hdr.sgml : 20211201
20211201202502
ACCESSION NUMBER: 0001104659-21-145591
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211129
FILED AS OF DATE: 20211201
DATE AS OF CHANGE: 20211201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cuca Roberto
CENTRAL INDEX KEY: 0001591474
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39130
FILM NUMBER: 211464613
MAIL ADDRESS:
STREET 1: C/O TREVENA, INC.
STREET 2: 1018 WEST 8TH AVENUE, SUITE A
CITY: KING OF PRUSSIA
STATE: PA
ZIP: 19406
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TELA Bio, Inc.
CENTRAL INDEX KEY: 0001561921
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 455320061
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 GREAT VALLEY PARKWAY, SUITE 24
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 484-320-2930
MAIL ADDRESS:
STREET 1: 1 GREAT VALLEY PARKWAY, SUITE 24
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
tm2134403d1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-11-29
0
0001561921
TELA Bio, Inc.
TELA
0001591474
Cuca Roberto
C/O TELA BIO, INC.
1 GREAT VALLEY PARKWAY, SUITE 24
MALVERN
PA
19355
0
1
0
0
COO and CFO
Common Stock
2021-11-29
4
P
0
423
12.60
A
423
D
Common Stock
2021-11-30
4
P
0
838
12.43
A
1261
D
Common Stock
2021-12-01
4
P
0
1780
12.64
A
3041
D
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.41 to $12.74. The Reporting Person undertakes to provide TELA Bio, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.40 to $12.49. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.55 to $12.65. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
/s/ Roberto Cuca
2021-12-01